Press Release
Category Added in a WPeMatico Campaign
-
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million
Non-dilutive strategic transaction expected to extend cash runway into 2029, to advance Compugen’s innovative immuno-oncology pipeline and to reach potential…
Read More » -
Business Wire6 days ago
GMO GlobalSign Wraps 2025 with Breakthroughs in Certificate Lifecycle Automation and Email Trust Solutions
In 2025, top certificate authority rolled out innovative options for companies to automate Public Key Infrastructure and improve email legitimacy…
Read More » -
Business Wire6 days ago
Exchange Income Corporation Announces December 2025 Dividend
WINNIPEG, Manitoba–(BUSINESS WIRE)–$EIF #TSX–Exchange Income Corporation (TSX: EIF) (the “Corporation”), a diversified, acquisition-oriented company focused on opportunities in the Aerospace…
Read More » -
Business Wire6 days ago
Akamai and Visa Collaborate to Build Trust in Agentic Commerce
Visa’s Trusted Agent Protocol to authenticate AI shopping agents and help prevent fraud across Akamai Cloud, strengthening the trust layer…
Read More » -
Business Wire6 days ago
Infinity Natural Resources Publishes Updated Hedge Positions
MORGANTOWN, W. Va.–(BUSINESS WIRE)–Infinity Natural Resources, Inc. (“Infinity” or the “Company”) (NYSE: INR) (INR) today provided an update on its…
Read More » -
Business Wire6 days ago
Gelt Launches AI-Powered Tax Calculator Hub to Quantify the Value of Advanced Tax Strategies Ahead of 2026 Tax Season
New hub delivers fast, dollar-based insights for S Corp elections, PTET, and other high-impact strategies. MIAMI–(BUSINESS WIRE)–Gelt, the AI-native tax…
Read More » -
Viatris to Present at the 44th Annual J.P. Morgan Healthcare Conference
PITTSBURGH, Dec. 17, 2025 /PRNewswire/ — Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the Company will…
Read More » -
Sealed Air Announces Expiration of “Go-Shop” Period
Transaction is Expected to Close in Mid-2026 CHARLOTTE, N.C., Dec. 17, 2025 /PRNewswire/ — Sealed Air Corporation (“Sealed Air” or the…
Read More » -
Protalix Biotherapeutics and Secarna Pharmaceuticals Enter into Collaboration and Option Agreement
Partnership combines Protalix’s rare disease and biologics expertise with Secarna’s AI–powered OligoCreator® platform to jointly develop pharmaceutical candidates for rare…
Read More » -
PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
PADCEV plus Keytruda is the first and only regimen without platinum-based chemotherapy to improve event-free and overall survival when used…
Read More »